Fulgent Genetics (FLGT) Net Income (2015 - 2026)

Fulgent Genetics (FLGT) has 11 years of Net Income data on file, last reported at -$25.3 million in Q1 2026.

• Quarterly Net Income fell 112.01% year-over-year to -$25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.3 million (up 61.01% YoY) and the FY2025 annual result came in at -$1.0 million, up 97.4% from the prior year.
• Net Income slipped to -$25.3 million in Q1 2026 per FLGT's latest filing, from $37.0 million in the prior quarter.
• The five-year high for Net Income was $153.6 million in Q1 2022, with the low at -$25.3 million in Q1 2026.
• Average Net Income over 5 years is $3.6 million, with a median of -$11.6 million recorded in 2023.
• Year-over-year, Net Income slumped 1100.74% in 2023 and jumped 3631.52% in 2025.
• Fulgent Genetics' Net Income stood at -$24.1 million in 2022, then soared by 202.09% to $24.6 million in 2023, then plunged by 104.26% to -$1.0 million in 2024, then jumped by 3631.52% to $37.0 million in 2025, then plunged by 168.37% to -$25.3 million in 2026.
• Business Quant data shows FLGT's Net Income at -$25.3 million in Q1 2026, $37.0 million in Q4 2025, and -$6.8 million in Q3 2025.